Abstract
Sepsis is a major public health problem in children throughout the world. Given that the treatment guidelines emphasize early recognition, there is interest in developing biomarkers of sepsis, and most attention is focused on diagnostic biomarkers. While there is a need for ongoing discovery and development of diagnostic biomarkers for sepsis, this review will focus on less well-known applications of sepsis biomarkers. Among patients with sepsis, the biomarkers can give information regarding the risk of poor outcome from sepsis, risk of sepsis-related organ dysfunction, and subgroups of patients with sepsis who share underlying biological features potentially amenable to targeted therapeutics. These types of biomarkers, beyond the traditional concept of diagnosis, address the important concepts of prognostic and predictive enrichment, which are key components of bringing the promise of precision medicine to the bedside of children with sepsis.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Weiss, S. L. et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr. Crit. Care Med. 21, e52–e106 (2020).
Leticia Fernandez-Carballo, B., Escadafal, C., MacLean, E., Kapasi, A. J. & Dittrich, S. Distinguishing bacterial versus non-bacterial causes of febrile illness - a systematic review of host biomarkers. J. Infect. 82, 1–10 (2021).
Sweeney, T. E., Shidham, A., Wong, H. R. & Khatri, P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci. Transl. Med. 7, 287ra271 (2015).
Sweeney, T. E. & Khatri, P. Comprehensive validation of the FAIM3:PLAC8 ratio in time-matched public gene expression data. Am. J. Respir. Crit. Care Med. 192, 1260–1261 (2015).
Andres-Terre, M. et al. Integrated, multi-cohort analysis identifies conserved transcriptional signatures across multiple respiratory viruses. Immunity 43, 1199–1211 (2015).
Sweeney, T. E., Wong, H. R. & Khatri, P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci. Transl. Med. 8, 346ra391 (2016).
Mayhew, M. B. et al. A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections. Nat. Commun. 11, 1177 (2020).
Ducharme, J. et al. A multi-mRNA host-response molecular blood test for the diagnosis and prognosis of acute infections and sepsis: proceedings from a clinical advisory panel. J. Pers. Med. 10, 266 (2020).
Thair S. et al. Gene expression-based diagnosis of infections in critically ill patients-prospective validation of the sepsis metascore in a longitudinal severe trauma cohort. Crit. Care Med. https://doi.org/10.1097/CCM.0000000000005027, Online ahead of print (2021).
Mahajan, P. et al. Association of RNA biosignatures with bacterial infections in febrile infants aged 60 days or younger. JAMA 316, 846–857 (2016).
Herberg, J. A. et al. Diagnostic test accuracy of a 2-transcript host RNA signature for discriminating bacterial vs viral infection in febrile children. JAMA 316, 835–845 (2016).
Sampson, D. et al. Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study. BMC Med. 18, 185 (2020).
Conway, S. R. & Wong, H. R. Biomarker panels in critical care. Crit. Care Clin. 36, 89–104 (2020).
Goldstein, B., Giroir, B. & Randolph, A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr. Crit. Care Med. 6, 2–8 (2005).
Stanski, N. L. & Wong, H. R. Prognostic and predictive enrichment in sepsis. Nat. Rev. Nephrol. 16, 20–31 (2020).
Weiss, S. L. et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am. J. Respir. Crit. Care Med. 191, 1147 (2015).
Fleischmann, C. et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch. Dis. Child. https://doi.org/10.1136/archdischild-2020-320217, Online ahead of print (2021).
Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 395, 200–211 (2020).
Prescott, H. C., Calfee, C. S., Thompson, B. T., Angus, D. C. & Liu, V. X. Toward smarter lumping and smarter splitting: rethinking strategies for sepsis and acute respiratory distress syndrome clinical trial design. Am. J. Respir. Crit. Care Med. 194, 147–155 (2016).
Wong, H. R. et al. The pediatric sepsis biomarker risk model. Crit. Care 16, R174 (2012).
Wong, H. R. et al. Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS ONE 9, e86242 (2014).
Wong, H. R. et al. Improved risk stratification in pediatric septic shock using both protein and mRNA biomarkers. PERSEVERE-XP. Am. J. Respir. Crit. Care Med. 196, 494–501 (2017).
Wong, H. R. et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am. J. Respir. Crit. Care Med. 178, 276–282 (2008).
Kaplan, J. M. & Wong, H. R. Biomarker discovery and development in pediatric critical care medicine. Pediatr. Crit. Care Med. 12, 165–173 (2011).
Wong, H. R. et al. Pediatric sepsis biomarker risk Model-II: redefining the pediatric sepsis biomarker risk model with septic shock phenotype. Crit. Care Med. 44, 2010–2017 (2016).
Wong, H. R. et al. Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model. Sci. Transl. Med. 11, eaax9000 (2019).
Wong, H. R. et al. Biomarkers for estimating risk of hospital mortality and long-term quality-of-life morbidity after surviving pediatric septic shock: a secondary analysis of the life after pediatric sepsis evaluation investigation. Pediatr. Crit. Care Med. 22, 8–15 (2021).
Sweeney, T. E. et al. A community approach to mortality prediction in sepsis via gene expression analysis. Nat. Commun. 9, 694 (2018).
Banerjee, S., Mohammed, A., Wong, H. R., Palaniyar, N. & Kamaleswaran, R. Machine learning identifies complicated sepsis course and subsequent mortality based on 20 genes in peripheral blood immune cells at 24 h post-ICU admission. Front. Immunol. 12, 592303 (2021).
Manrique-Caballero, C. L., Del Rio-Pertuz, G. & Gomez, H. Sepsis-associated acute kidney injury. Crit. Care Clin. 37, 279–301 (2021).
Stanski, N. L., Cvijanovich, N. Z., Fitzgerald, J. C., Bigham, M. T. & Wong, H. R. Severe acute kidney injury is independently associated with mortality in children with septic shock. Intens. Care Med. 46, 1050–1051 (2020).
Stanski, N. L. et al. PERSEVERE biomarkers predict severe acute kidney injury and renal recovery in pediatric septic shock. Am. J. Respir. Crit. Care Med. 201, 848–855 (2020).
Jacobs, L. et al. The Pediatric Sepsis Biomarker Risk Model (PERSEVERE) biomarkers predict clinical deterioration and mortality in immunocompromised children evaluated for infection. Sci. Rep. 9, 424 (2019).
DeMerle, K. M. et al. Sepsis subclasses: a framework for development and interpretation. Crit. Care Med. 49, 748–759 (2021).
Davenport, E. E. et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir. Med. 4, 259–271 (2016).
Burnham, K. L. et al. Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia. Am. J. Respir. Crit. Care Med. 196, 328–339 (2017).
Scicluna, B. P. et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir. Med. 5, 816–826 (2017).
Sweeney, T. E. et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit. Care Med. 46, 915–925 (2018).
Iglesias, J. et al. A 33-mRNA classifier is able to produce inflammopathic, adaptive, and coagulopathic endotypes with prognostic significance: the Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial. J. Pers. Med. 11, 9 (2020).
Sweeney, T. E. et al. Validation of inflammopathic, adaptive, and coagulopathic sepsis endotypes in coronavirus disease 2019. Crit. Care Med. 49, e170–e178 (2021).
Wong, H. R. et al. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med. 7, 34 (2009).
Wong, H. R. et al. Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit. Care Med. 39, 2511–2517 (2011).
Wong, H. R. et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am. J. Respir. Crit. Care Med. 191, 309–315 (2015).
Wong, H. R. et al. Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit. Care Med. 38, 1955–1961 (2010).
Wong, H. R. et al. Endotype transitions during the acute phase of pediatric septic shock reflect changing risk and treatment response. Crit. Care Med. 46, e242–e249 (2018).
Wong, H. R., Sweeney, T. E., Hart, K. W., Khatri, P. & Lindsell, C. J. Pediatric sepsis endotypes among adults with sepsis. Crit. Care Med. 45, e1289–e1291 (2017).
Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862–874 (2013).
Hutchins, N. A., Unsinger, J., Hotchkiss, R. S. & Ayala, A. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol. Med. 20, 224–233 (2014).
Venkatesh, B. & Cohen, J. Hydrocortisone in vasodilatory shock. Crit. Care Clin. 35, 263–275 (2019).
Annane, D. et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N. Engl. J. Med. 378, 809–818 (2018).
Annane, D. et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288, 862–871 (2002).
Sprung, C. L. et al. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 358, 111–124 (2008).
Venkatesh, B. et al. Adjunctive glucocorticoid therapy in patients with septic shock. N. Engl. J. Med. 378, 797–808 (2018).
Antcliffe, D. B. & Gordon, A. C. Why understanding sepsis endotypes is important for steroid trials in septic shock. Crit. Care Med. 47, 1782–1784 (2019).
Gordon, A. C. et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH Randomized Clinical Trial. JAMA 316, 509–518 (2016).
Antcliffe, D. B. et al. Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH Randomized Trial. Am. J. Respir. Crit. Care Med. 199, 980–986 (2019).
Wong, H. R., Hart, K. W., Lindsell, C. J. & Sweeney, T. E. External corroboration that corticosteroids may be harmful to septic shock endotype a patients. Crit. Care Med. 49, e98–e101 (2021).
Wong, H. R. et al. Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids. Crit. Care Med. 44, e1000–e1003 (2016).
Acknowledgements
This work was funded by the National Institute of General Medical Sciences, R35GM126943 (to H.R.W.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
H.R.W. and the Cincinnati Children’s Hospital Research Foundation hold US patents for the PERSEVERE biomarkers and the pediatric septic shock endotyping strategy described in the manuscript.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wong, H.R. Pediatric sepsis biomarkers for prognostic and predictive enrichment. Pediatr Res 91, 283–288 (2022). https://doi.org/10.1038/s41390-021-01620-5
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41390-021-01620-5
This article is cited by
-
Microvascular phenotypes in pediatric sepsis identified by machine learning: prognostic implications for organ dysfunction and mortality
Critical Care (2026)
-
Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review
Critical Care (2025)
-
Prognostic and clinical indicators of sepsis outcomes in hospitalized patients: a cross-sectional study
BMC Infectious Diseases (2025)
-
Elevated total bile acid levels as an independent predictor of mortality in pediatric sepsis
Pediatric Research (2025)
-
Identification of the Shared Gene Signatures of HCK, NOG, RNF125 and Biological Mechanism in Pediatric Acute Lymphoblastic Leukaemia and Pediatric Sepsis
Molecular Biotechnology (2025)
